F1PART 12ASale of medicines to the public at a distance

Annotations:
Amendments (Textual)
F1

Pt. 12A inserted (coming into force in accordance with reg. 1(2) of the amending S.I.) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(2), 28

Grant or refusal to list a person256G

1

On receipt of a notification from a person to be included in the list—

a

the F2licensing authority must include that person on the list if that person complies with the requirements in regulation 256C(2) to (5); or

b

if it considers necessary or appropriate to do so, the F2licensing authority must refuse to include that person on the list having had regard to—

i

the provisions of these Regulations, and

ii

any EU obligation.

2

The F2licensing authority must give a notice stating the reasons for its decision in any case where F3the licensing authority—

a

refuses to include a person on the list; or

b

includes a person in the list otherwise than in accordance with the notification and that person requests a statement of its reasons.

3

Where the F2licensing authority decides to include a person on the list F4the licensing authority must ensure that the F5website of the licensing authority includes—

a

the name or corporate name of the person that is listed; and

b

the person’s website address in the United Kingdom.